Document Detail


Severe type III hyperlipoproteinemia in two patients maintained on chronic hemodialysis.
MedLine Citation:
PMID:  2319734     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Two patients with severe hyperlipidemia receiving long-term hemodialysis were classified as type III hyperlipoproteinemic subjects. They are homozygous for apolipoprotein E2 and have an elevated VLDL-cholesterol/plasma-triglyceride ratio. The dyslipoproteinemia was severely aggravated by the renal failure, but careful treatment with bezafibrate was able to effectively lower elevated serum lipids. Accurate diagnosis of lipid abnormalities in patients with chronic renal failure seems to be necessary to plan appropriate therapeutic interventions and to lower the risk for accelerated atherosclerosis.
Authors:
G Feussner; J Bommer; R Ziegler
Related Documents :
15016774 - Hypothalamic-pituitary-gonadal axis function after successful kidney transplantation in...
1589374 - Raised blood urea in the elderly: a clinical and pathological study.
17524854 - Time-dependent variations in urine output after renal transplantation.
22142654 - Balanced vs unbalanced crystalloid resuscitation in a near-fatal model of hemorrhagic s...
15047654 - L-arginine-induced vasodilation of the renal vasculature is preserved in uremic type 1 ...
4306854 - Liver transplantation in man--3, studies of liver function, histology, and immunosuppre...
Publication Detail:
Type:  Case Reports; Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Klinische Wochenschrift     Volume:  68     ISSN:  0023-2173     ISO Abbreviation:  Klin. Wochenschr.     Publication Date:  1990 Jan 
Date Detail:
Created Date:  1990-05-03     Completed Date:  1990-05-03     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  2985205R     Medline TA:  Klin Wochenschr     Country:  GERMANY, WEST    
Other Details:
Languages:  eng     Pagination:  65-70     Citation Subset:  IM    
Affiliation:
Medizinische Klinik der Universität Heidelberg, Abteilung Innere Medizin I.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Apolipoproteins E / blood,  genetics
Arteriosclerosis / blood*
Bezafibrate / administration & dosage
Cholesterol / blood
Female
Heterozygote Detection
Humans
Hyperlipoproteinemia Type III / blood*,  drug therapy,  genetics
Kidney Failure, Chronic / blood*
Kidney Function Tests
Lipids / blood*
Lipoproteins / blood
Middle Aged
Renal Dialysis*
Risk Factors
Triglycerides / blood
Chemical
Reg. No./Substance:
0/Apolipoproteins E; 0/Lipids; 0/Lipoproteins; 0/Triglycerides; 41859-67-0/Bezafibrate; 57-88-5/Cholesterol

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Lipolytic enzymes of the human pancreas. III. Auxiliary function of lipase in the cholesterol-estera...
Next Document:  Effect of diabetes-psychosomatic group education on metabolic control and coping with disease by ins...